Life sciences commercial teams continue to evolve as they absorb the long-term impacts of COVID-19. As we transition from pandemic to endemic status, two primary areas of focus deserve renewed attention - launch strategy and cancer treatment insights. In our June quarterly webinar series, we turn our focus to these key topics.

Join us to learn:

• Pointers from resilient post-pandemic launches that will inform future launch excellence
• How the rules for establishing long-term launch success have changed
• What specific types of cancer treatments have been impacted most by COVID-19
• Updates on cancer patient backlogs